News 
Market Data 
Discover
Replies to post #8 on Senti Biosciences Inc (SNTI)
10/04/23 4:50 AM
$SNTI Senti Biosciences has received a Notice of Allowance for its US patent application 17/338,528 titled "CHIMERIC RECEPTORS AND METHODS OF USE THEREOF (FOR TREATMENT OF ACUTE MYELOID LEUKEMIA)". https://t.co/YAXik6A33A pic.twitter.com/ExNJ0YYhum
— PatentGrants (@PatentGrants) October 3, 2023
TOP WATCH $SNTI on REVERSAL WATCH
— Thinking (@PromotingLife1) October 4, 2023
PATEN T NEWS FOR LEUKIMIA
$6 PT
AI
